Study: MPR better for predicting death risk

06/29/2011 | MolecularImaging.net

Myocardial perfusion reserve is a more effective indicator of cardiac death risk than left ventricular ejection fraction and viability range in patients with ischemic heart disease who underwent a PET-driven procedure, according to a study published in the Journal of Nuclear Medicine. "The advantage of PET is that on top of viability, absolute myocardial perfusion can be measured. In addition, MPR can be assessed using vasodilator substances," the Dutch-led researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC